• Published On : Jul-2017 |
  • Pages : 232 Pages |
  • Format :

1. Executive Summary
   1.1. Market Overview
   1.2. Market Analysis
   1.3. PMR Analysis and Recommendations
   1.4. Wheel of Fortune

2. Market Introduction
   2.1. Market Definition
   2.2. Market Taxonomy

3. Veterinary Anti-Infectives Market Opportunity Analysis 
   3.1. Opportunity Analysis
   3.2. Trend Analysis

4. North America Veterinary Anti-Infectives Market Analysis 2012–2016 and Forecast 2017–2025
   4.1. Introduction
   4.2. Regional Market Dynamics
        4.2.1. Drivers
        4.2.2. Restraints
        4.2.3. Trends
   4.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
        4.3.1. U.S.
        4.3.2. Canada
   4.4. Market Size (US$ Mn) Forecast By Country, 2017–2025
        4.4.1. U.S.
        4.4.2. Canada
   4.5. Historical Market Size (US$ Mn) Trend Analysis By Species, 2012–2016
        4.5.1. Livestock Animals
        4.5.2. Companion Animals 
   4.6. Market Size (US$ Mn) Forecast By Species, 2017–2025
        4.6.1. Livestock Animals
        4.6.2. Companion Animals 
   4.7. Historical Market Size (US$ Mn) Trend Analysis By Drug Class, 2012–2016
        4.7.1. Antimicrobial Agents
               4.7.1.1. Tetracycline
               4.7.1.2. Penicillin
               4.7.1.3. Cephalosporin
               4.7.1.4. Macrolides
               4.7.1.5. Quinolones
               4.7.1.6. Others
        4.7.2. Antiviral Agents
        4.7.3. Antifungal Agents
        4.7.4. Antiphrastic Agents
   4.8. Market Size (US$ Mn) Forecast By Drug Class, 2017–2025
        4.8.1. Antimicrobial Agents
               4.8.1.1. Tetracycline
               4.8.1.2. Penicillin
               4.8.1.3. Cephalosporin
               4.8.1.4. Macrolides
               4.8.1.5. Quinolones
               4.8.1.6. Others
        4.8.2. Antiviral Agents
        4.8.3. Antifungal Agents
        4.8.4. Antiphrastic Agents
   4.9. Historical Market Size (US$ Mn) Trend Analysis By Mode of Administration, 2012–2016
        4.9.1. Oral
        4.9.2. Parenteral
        4.9.3. Topical   
   4.10. Market Size (US$ Mn) Forecast By Mode of Administration, 2017–2025
        4.10.1. Oral
        4.10.2. Parenteral
        4.10.3. Topical   
   4.11. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel , 2012–2016
        4.11.1. Veterinary Hospitals
        4.11.2. Veterinary Clinics
        4.11.3. Pharmacies
        4.11.4. Others  
   4.12. Market Size (US$ Mn) Forecast By Distribution Channel , 2017–2025
        4.12.1. Veterinary Hospitals
        4.12.2. Veterinary Clinics
        4.12.3. Pharmacies
        4.12.4. Others     
   4.13. Drivers and Restraints: Impact Analysis
   4.14. Market Attractiveness Analysis
        4.14.1. By Country
        4.14.2. By Species
        4.14.3. By Drug Class
        4.14.4. By Mode of Administration
        4.14.5. By Distribution Channel
   4.15. Key Representative Market Participants
   4.16. Market Presence (Intensity Map)

5. Latin America Veterinary Anti-Infectives Market Analysis 2012–2016 and Forecast 2017–2025
   5.1. Introduction
   5.2. Key Regulations
   5.3. Regional Market Dynamics
        5.3.1. Drivers
        5.3.2. Restraints
        5.3.3. Trends
   5.4. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
        5.4.1. Brazil
        5.4.2. Mexico
        5.4.3. Argentina
        5.4.4. Rest of Latin America
   5.5. Market Size (US$ Mn) Forecast By Country, 2017–2025
        5.5.1. Brazil
        5.5.2. Mexico
        5.5.3. Argentina
        5.5.4. Rest of Latin America
   5.6. Historical Market Size (US$ Mn) Trend Analysis By Species, 2012–2016
        5.6.1. Livestock Animals
        5.6.2. Companion Animals 
   5.7. Market Size (US$ Mn) Forecast By Species, 2017–2025
        5.7.1. Livestock Animals
        5.7.2. Companion Animals 
   5.8. Historical Market Size (US$ Mn) Trend Analysis By Drug Class, 2012–2016
        5.8.1. Antimicrobial Agents
               5.8.1.1. Tetracycline
               5.8.1.2. Penicillin
               5.8.1.3. Cephalosporin
               5.8.1.4. Macrolides
               5.8.1.5. Quinolones
               5.8.1.6. Others
        5.8.2. Antiviral Agents
        5.8.3. Antifungal Agents
        5.8.4. Antiphrastic Agents
   5.9. Market Size (US$ Mn) Forecast By Drug Class, 2017–2025
        5.9.1. Antimicrobial Agents
               5.9.1.1. Tetracycline
               5.9.1.2. Penicillin
               5.9.1.3. Cephalosporin
               5.9.1.4. Macrolides
               5.9.1.5. Quinolones
               5.9.1.6. Others
        5.9.2. Antiviral Agents
        5.9.3. Antifungal Agents
        5.9.4. Antiphrastic Agents
   5.10. Historical Market Size (US$ Mn) Trend Analysis By Mode of Administration, 2012–2016
        5.10.1. Oral
        5.10.2. Parenteral
        5.10.3. Topical   
   5.11. Market Size (US$ Mn) Forecast By Mode of Administration, 2017–2025
        5.11.1. Oral
        5.11.2. Parenteral
        5.11.3. Topical   
   5.12. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel , 2012–2016
        5.12.1. Veterinary Hospitals
        5.12.2. Veterinary Clinics
        5.12.3. Pharmacies
        5.12.4. Others  
   5.13. Market Size (US$ Mn) Forecast By Distribution Channel , 2017–2025
        5.13.1. Veterinary Hospitals
        5.13.2. Veterinary Clinics
        5.13.3. Pharmacies
        5.13.4. Others     
   5.14. Drivers and Restraints: Impact Analysis
   5.15. Market Attractiveness Analysis
        5.15.1. By Country
        5.15.2. By Species
        5.15.3. By Drug Class
        5.15.4. By Mode of Administration
        5.15.5. By Distribution Channel
   5.16. Key Representative Market Participants
   5.17. Market Presence (Intensity Map)

6. Europe Veterinary Anti-Infectives Market Analysis 2012–2016 and Forecast 2017–2025
   6.1. Introduction
   6.2. Key Regulations
   6.3. Regional Market Dynamics
        6.3.1. Drivers
        6.3.2. Restraints
        6.3.3. Trends
   6.4. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
        6.4.1. Germany
        6.4.2. France
        6.4.3. Russia
        6.4.4. Italy
        6.4.5. Spain
        6.4.6. U.K.
        6.4.7. Netherlands 
        6.4.8. Rest of Europe
   6.5. Market Size (US$ Mn) Forecast By Country, 2017–2025
        6.5.1. Germany
        6.5.2. France
        6.5.3. Russia
        6.5.4. Italy
        6.5.5. Spain
        6.5.6. U.K.
        6.5.7. Netherlands 
        6.5.8. Rest of Europe
   6.6. Historical Market Size (US$ Mn) Trend Analysis By Species, 2012–2016
        6.6.1. Livestock Animals
        6.6.2. Companion Animals 
   6.7. Market Size (US$ Mn) Forecast By Species, 2017–2025
        6.7.1. Livestock Animals
        6.7.2. Companion Animals 
   6.8. Historical Market Size (US$ Mn) Trend Analysis By Drug Class, 2012–2016
        6.8.1. Antimicrobial Agents
               6.8.1.1. Tetracycline
               6.8.1.2. Penicillin
               6.8.1.3. Cephalosporin
               6.8.1.4. Macrolides
               6.8.1.5. Quinolones
               6.8.1.6. Others
        6.8.2. Antiviral Agents
        6.8.3. Antifungal Agents
        6.8.4. Antiphrastic Agents
   6.9. Market Size (US$ Mn) Forecast By Drug Class, 2017–2025
        6.9.1. Antimicrobial Agents
               6.9.1.1. Tetracycline
               6.9.1.2. Penicillin
               6.9.1.3. Cephalosporin
               6.9.1.4. Macrolides
               6.9.1.5. Quinolones
               6.9.1.6. Others
        6.9.2. Antiviral Agents
        6.9.3. Antifungal Agents
        6.9.4. Antiphrastic Agents
   6.10. Historical Market Size (US$ Mn) Trend Analysis By Mode of Administration, 2012–2016
        6.10.1. Oral
        6.10.2. Parenteral
        6.10.3. Topical   
   6.11. Market Size (US$ Mn) Forecast By Mode of Administration, 2017–2025
        6.11.1. Oral
        6.11.2. Parenteral
        6.11.3. Topical   
   6.12. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel , 2012–2016
        6.12.1. Veterinary Hospitals
        6.12.2. Veterinary Clinics
        6.12.3. Pharmacies
        6.12.4. Others  
   6.13. Market Size (US$ Mn) Forecast By Distribution Channel , 2017–2025
        6.13.1. Veterinary Hospitals
        6.13.2. Veterinary Clinics
        6.13.3. Pharmacies
        6.13.4. Others     
   6.14. Drivers and Restraints: Impact Analysis
   6.15. Market Attractiveness Analysis
        6.15.1. By Country
        6.15.2. By Species
        6.15.3. By Drug Class
        6.15.4. By Mode of Administration
        6.15.5. By Distribution Channel
   6.16. Key Representative Market Participants
   6.17. Market Presence (Intensity Map)

7. Asia Pacific Veterinary Anti-Infectives Market Analysis 2012–2016 and Forecast 2017–2025
   7.1. Introduction
   7.2. Key Regulations
   7.3. Regional Market Dynamics
        7.3.1. Drivers
        7.3.2. Restraints
        7.3.3. Trends
   7.4. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
        7.4.1. China
        7.4.2. India
        7.4.3. Japan
        7.4.4. Australia and New Zealand
        7.4.5. Rest of Asia Pacific
   7.5. Market Size (US$ Mn) Forecast By Country, 2017–2025
        7.5.1. China
        7.5.2. India
        7.5.3. Japan
        7.5.4. Australia and New Zealand
        7.5.5. Rest of Asia Pacific
   7.6. Historical Market Size (US$ Mn) Trend Analysis By Species, 2012–2016
        7.6.1. Livestock Animals
        7.6.2. Companion Animals 
   7.7. Market Size (US$ Mn) Forecast By Species, 2017–2025
        7.7.1. Livestock Animals
        7.7.2. Companion Animals 
   7.8. Historical Market Size (US$ Mn) Trend Analysis By Drug Class, 2012–2016
        7.8.1. Antimicrobial Agents
               7.8.1.1. Tetracycline
               7.8.1.2. Penicillin
               7.8.1.3. Cephalosporin
               7.8.1.4. Macrolides
               7.8.1.5. Quinolones
               7.8.1.6. Others
        7.8.2. Antiviral Agents
        7.8.3. Antifungal Agents
        7.8.4. Antiphrastic Agents
   7.9. Market Size (US$ Mn) Forecast By Drug Class, 2017–2025
        7.9.1. Antimicrobial Agents
               7.9.1.1. Tetracycline
               7.9.1.2. Penicillin
               7.9.1.3. Cephalosporin
               7.9.1.4. Macrolides
               7.9.1.5. Quinolones
               7.9.1.6. Others
        7.9.2. Antiviral Agents
        7.9.3. Antifungal Agents
        7.9.4. Antiphrastic Agents
   7.10. Historical Market Size (US$ Mn) Trend Analysis By Mode of Administration, 2012–2016
        7.10.1. Oral
        7.10.2. Parenteral
        7.10.3. Topical   
   7.11. Market Size (US$ Mn) Forecast By Mode of Administration, 2017–2025
        7.11.1. Oral
        7.11.2. Parenteral
        7.11.3. Topical   
   7.12. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel , 2012–2016
        7.12.1. Veterinary Hospitals
        7.12.2. Veterinary Clinics
        7.12.3. Pharmacies
        7.12.4. Others  
   7.13. Market Size (US$ Mn) Forecast By Distribution Channel , 2017–2025
        7.13.1. Veterinary Hospitals
        7.13.2. Veterinary Clinics
        7.13.3. Pharmacies
        7.13.4. Others     
   7.14. Drivers and Restraints: Impact Analysis
   7.15. Market Attractiveness Analysis
        7.15.1. By Country
        7.15.2. By Species
        7.15.3. By Drug Class
        7.15.4. By Mode of Administration
        7.15.5. By Distribution Channel
   7.16. Key Representative Market Participants
   7.17. Market Presence (Intensity Map)

8. Middle East & Africa Veterinary Anti-Infectives Market Analysis 2012–2016 and Forecast 2017–2025
   8.1. Introduction
   8.2. Key Regulations
   8.3. Regional Market Dynamics
        8.3.1. Drivers
        8.3.2. Restraints
        8.3.3. Trends
   8.4. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
        8.4.1. GCC Countries
        8.4.2. South Africa
        8.4.3. Turkey
        8.4.4. Rest of MEA
   8.5. Market Size (US$ Mn) Forecast By Country, 2017–2025
        8.5.1. GCC Countries
        8.5.2. South Africa
        8.5.3. Turkey
        8.5.4. Rest of MEA
   8.6. Historical Market Size (US$ Mn) Trend Analysis By Species, 2012–2016
        8.6.1. Livestock Animals
        8.6.2. Companion Animals 
   8.7. Market Size (US$ Mn) Forecast By Species, 2017–2025
        8.7.1. Livestock Animals
        8.7.2. Companion Animals 
   8.8. Historical Market Size (US$ Mn) Trend Analysis By Drug Class, 2012–2016
        8.8.1. Antimicrobial Agents
               8.8.1.1. Tetracycline
               8.8.1.2. Penicillin
               8.8.1.3. Cephalosporin
               8.8.1.4. Macrolides
               8.8.1.5. Quinolones
               8.8.1.6. Others
        8.8.2. Antiviral Agents
        8.8.3. Antifungal Agents
        8.8.4. Antiphrastic Agents
   8.9. Market Size (US$ Mn) Forecast By Drug Class, 2017–2025
        8.9.1. Antimicrobial Agents
               8.9.1.1. Tetracycline
               8.9.1.2. Penicillin
               8.9.1.3. Cephalosporin
               8.9.1.4. Macrolides
               8.9.1.5. Quinolones
               8.9.1.6. Others
        8.9.2. Antiviral Agents
        8.9.3. Antifungal Agents
        8.9.4. Antiphrastic Agents
   8.10. Historical Market Size (US$ Mn) Trend Analysis By Mode of Administration, 2012–2016
        8.10.1. Oral
        8.10.2. Parenteral
        8.10.3. Topical   
   8.11. Market Size (US$ Mn) Forecast By Mode of Administration, 2017–2025
        8.11.1. Oral
        8.11.2. Parenteral
        8.11.3. Topical   
   8.12. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel , 2012–2016
        8.12.1. Veterinary Hospitals
        8.12.2. Veterinary Clinics
        8.12.3. Pharmacies
        8.12.4. Others  
   8.13. Market Size (US$ Mn) Forecast By Distribution Channel , 2017–2025
        8.13.1. Veterinary Hospitals
        8.13.2. Veterinary Clinics
        8.13.3. Pharmacies
        8.13.4. Others     
   8.14. Drivers and Restraints: Impact Analysis
   8.15. Market Attractiveness Analysis
        8.15.1. By Country
        8.15.2. By Species
        8.15.3. By Drug Class
        8.15.4. By Mode of Administration
        8.15.5. By Distribution Channel
   8.16. Key Representative Market Participants
   8.17. Market Presence (Intensity Map)

9. Forecast Factors: Relevance and Impact

10. Forecast Assumptions

11. Competition Landscape
   11.1. Competition Dashboard
   11.2. Company Profiles (Details – Overview, Financials, Strategy, SWOT, Recent Developments)
        11.2.1. Bayer AG
        11.2.2. Cipla Limited
        11.2.3. Dechra Pharmaceuticals PLC
        11.2.4. Eli Lilly and Company (Elanco Animal Health)
        11.2.5. Heska Corp (Diamond Animal Health)
        11.2.6. Merck & Co., Inc. (Merck Animal Health)
        11.2.7. Neogen Corporation
        11.2.8. Phibro Animal Health Corporation
        11.2.9. Sanofi (Merial Animal Health)
        11.2.10. Vetoquinol S.A.
        11.2.11. Virbac S.A.
        11.2.12. Zoetis, Inc.
        11.2.13. Boehringer Ingelheim GmbH
        11.2.14. Ceva Santé Animale
        11.2.15. Indian Immunologicals Limited
        11.2.16. Intas Pharmaceuticals Limited
        11.2.17. Norbrook Laboratories Limited
        11.2.18. Zydus Animal Health Limited
        11.2.19. Ashish Life Science Private Limited
        11.2.20. Oceanic Pharmachem Private Limited.

12. Global Veterinary Anti-Infectives Market Analysis 2012–2016 and Forecast 2017–2025, By Region
   12.1. Introduction/Key Findings
   12.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 2012–2016
        12.2.1. North America
        12.2.2. Latin America
        12.2.3. Europe
        12.2.4. Asia Pacific 
        12.2.5. Middle East & Africa
   12.3. Market Size (US$ Mn) Forecast By Region, 2017–2025
        12.3.1. North America
        12.3.2. Latin America
        12.3.3. Europe
        12.3.4. Asia Pacific 
        12.3.5. Middle East & Africa
   12.4. Market Attractiveness Analysis By Region

13. Global Veterinary Anti-Infectives Market Analysis 2012–2016 and Forecast 2017–2025, By Species
   13.1. Introduction/Key Findings
   13.2. Historical Market Size (US$ Mn) Trend Analysis By Species, 2012–2016
        13.2.1. Livestock Animals
        13.2.2. Companion Animals 
   13.3. Market Size (US$ Mn) and Forecast By Species, 2017–2025
        13.3.1. Livestock Animals
        13.3.2. Companion Animals 
   13.4. Market Attractiveness Analysis By Species

14. Global Veterinary Anti-Infectives Market Analysis 2012–2016 and Forecast 2017–2025, By Drug Class
   14.1. Introduction/Key Findings
   14.2. Historical Market Size (US$ Mn) Trend Analysis By Drug Class, 2012–2016
        14.2.1. Antimicrobial Agents
               14.2.1.1. Tetracycline
               14.2.1.2. Penicillin
               14.2.1.3. Cephalosporin
               14.2.1.4. Macrolides
               14.2.1.5. Quinolones
               14.2.1.6. Others
        14.2.2. Antiviral Agents
        14.2.3. Antifungal Agents
        14.2.4. Antiphrastic Agents
   14.3. Market Size (US$ Mn) Forecast By Drug Class, 2017–2025
        14.3.1. Antimicrobial Agents
               14.3.1.1. Tetracycline
               14.3.1.2. Penicillin
               14.3.1.3. Cephalosporin
               14.3.1.4. Macrolides
               14.3.1.5. Quinolones
               14.3.1.6. Others
        14.3.2. Antiviral Agents
        14.3.3. Antifungal Agents
        14.3.4. Antiphrastic Agents
   14.4. Market Attractiveness Analysis By Drug Class

15. Global Veterinary Anti-Infectives Market Analysis 2012–2016 and Forecast 2017–2025, By Mode of Administration
   15.1. Introduction/Key Findings
   15.2. Historical Market Size (US$ Mn) Trend Analysis By Mode of Administration, 2012–2016
        15.2.1. Oral
        15.2.2. Parenteral
        15.2.3. Topical   
   15.3. Market Size (US$ Mn) Forecast By Mode of Administration, 2017–2025
        15.3.1. Oral
        15.3.2. Parenteral
        15.3.3. Topical   
   15.4. Market Attractiveness Analysis By Mode of Administration

16. Global Veterinary Anti-Infectives Market Analysis 2012–2016 and Forecast 2017–2025, By Distribution Channel
   16.1. Introduction/Key Findings
   16.2. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2012–2016
        16.2.1. Veterinary Hospitals
        16.2.2. Veterinary Clinics
        16.2.3. Pharmacies
        16.2.4. Others     
   16.3. Market Size (US$ Mn) Forecast By Distribution Channel, 2017–2025
        16.3.1. Veterinary Hospitals
        16.3.2. Veterinary Clinics
        16.3.3. Pharmacies
        16.3.4. Others     
   16.4. Market Attractiveness Analysis By Distribution Channel

17. Global Veterinary Anti-Infectives Market Analysis 2012–2016 and Forecast 2017–2025
   17.1. Market Size and Y-o-Y Growth
   17.2. Absolute $ Opportunit


List of Table

Table 01: North America Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017–2025, By Country
Table 02: North America Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017–2025, By Species Type
Table 03: North America Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017–2025, By Drug Class
Table 04: North America Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017–2025, By Mode of Administration
Table 05: North America Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017–2025, By Distribution Channel
Table 06: Latin America Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017–2025, By Country
Table 07: Latin America Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017–2025, By Species Type
Table 08: Latin America Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017–2025, By Drug Class
Table 09: Latin America Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017–2025, By Mode of Administration
Table 10: Latin America Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017–2025, By Distribution Channel
Table 11: Europe Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017–2025, By Country
Table 12: Europe Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017–2025, By Species Type
Table 13: Europe Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017–2025, By Drug Class
Table 14: Europe Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017–2025, By Mode of Administration
Table 15: Europe Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017–2025, By Distribution Channel
Table 16: APAC Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017–2025, By Country
Table 17: APAC Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017–2025, By Species Type
Table 18: APAC Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017–2025, By Drug Class
Table 19: APAC Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017–2025, By Mode of Administration
Table 20: APAC Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017–2025, By Distribution Channel
Table 21: MEA Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017–2025, By Country
Table 22: MEA Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017–2025, By Species Type
Table 23: MEA Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017–2025, By Drug Class
Table 24: MEA Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017–2025, By Mode of Administration
Table 25: MEA Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017–2025, By Distribution Channel
Table 26: Global Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017–2025, By Region
Table 27: Global Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017–2025, By Species Type
Table 28: Global Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017–2025, By Drug Class
Table 29: Global Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017–2025, By Mode of Administration
Table 30: Global Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017–2025, By Distribution Channel


List of Figure

Figure 01: North America Veterinary Anti-Infectives Market Share Analysis (%) By Country, 2017 & 2025
Figure 02: North America Veterinary Anti-Infectives Market Y-o-Y Growth (%) By Country, 2016–2025
Figure 03: North America Veterinary Anti-Infectives Market Size Analysis, 2012-2016
Figure 04: North America Veterinary Anti-Infectives Market Forecast, 2017–2025
Figure 05: North America Veterinary Anti-Infectives Market Attractiveness Analysis, 2017–2025, by Country
Figure 06: North America Veterinary Anti-Infectives Market Attractiveness Analysis, 2017–2025, by Species Type
Figure 07: North America Veterinary Anti-Infectives Market Attractiveness Analysis, 2017–2025, by Drug Class
Figure 08: North America Veterinary Anti-Infectives Market Attractiveness Analysis, 2017–2025, by Mode of Administration
Figure 09: North America Veterinary Anti-Infectives Market Attractiveness Analysis, 2017–2025, by Distribution Channel
Figure 10: Latin America Veterinary Anti-Infectives Market Share Analysis (%) By Country, 2017 & 2025
Figure 11: Latin America Veterinary Anti-Infectives Market Y-o-Y Growth (%) By Country, 2016–2025
Figure 12: Latin America Veterinary Anti-Infectives Market Size Analysis, 2012-2016
Figure 13: Latin America Veterinary Anti-Infectives Market Forecast, 2017–2025
Figure 14: Latin America Veterinary Anti-Infectives Market Attractiveness Analysis, 2017–2025, by Country
Figure 15: Latin America Veterinary Anti-Infectives Market Attractiveness Analysis, 2017–2025, by Species Type
Figure 16: Latin America Veterinary Anti-Infectives Market Attractiveness Analysis, 2017–2025, by Drug Class
Figure 17: Latin America Veterinary Anti-Infectives Market Attractiveness Analysis, 2017–2025, by Mode of Administration
Figure 18: Latin America Veterinary Anti-Infectives Market Attractiveness Analysis, 2017–2025, by Distribution Channel
Figure 19: Europe Veterinary Anti-Infectives Market Share Analysis (%) By Country, 2017 & 2025
Figure 20: Europe Veterinary Anti-Infectives Market Y-o-Y Growth (%) By Country, 2016–2025
Figure 21: Europe Veterinary Anti-Infectives Market Size Analysis, 2012-2016
Figure 22: Europe Veterinary Anti-Infectives Market Forecast, 2017–2025
Figure 23: Europe Veterinary Anti-Infectives Market Attractiveness Analysis, 2017–2025, by Country
Figure 24: Europe Veterinary Anti-Infectives Market Attractiveness Analysis, 2017–2025, by Species Type
Figure 25: Europe Veterinary Anti-Infectives Market Attractiveness Analysis, 2017–2025, by Drug Class
Figure 26: Europe Veterinary Anti-Infectives Market Attractiveness Analysis, 2017–2025, by Mode of Administration
Figure 27: Europe Veterinary Anti-Infectives Market Attractiveness Analysis, 2017–2025, by Distribution Channel
Figure 28: APAC Veterinary Anti-Infectives Market Share Analysis (%) By Country, 2017 & 2025
Figure 29: APAC Veterinary Anti-Infectives Market Y-o-Y Growth (%) By Country, 2016–2025
Figure 30: APAC Veterinary Anti-Infectives Market Size Analysis, 2012-2016
Figure 31: APAC Veterinary Anti-Infectives Market Forecast, 2017–2025
Figure 32: APAC Veterinary Anti-Infectives Market Attractiveness Analysis, 2017–2025, by Country
Figure 33: APAC Veterinary Anti-Infectives Market Attractiveness Analysis, 2017–2025, by Species Type
Figure 34: APAC Veterinary Anti-Infectives Market Attractiveness Analysis, 2017–2025, by Drug Class
Figure 35: APAC Veterinary Anti-Infectives Market Attractiveness Analysis, 2017–2025, by Mode of Administration
Figure 36: APAC Veterinary Anti-Infectives Market Attractiveness Analysis, 2017–2025, by Distribution Channel
Figure 37: MEA Veterinary Anti-Infectives Market Share Analysis (%) By Country, 2017 & 2025
Figure 38: MEA Veterinary Anti-Infectives Market Y-o-Y Growth (%) By Country, 2016–2025
Figure 39: MEA Veterinary Anti-Infectives Market Size Analysis, 2012-2016
Figure 40: MEA Veterinary Anti-Infectives Market Forecast, 2017–2025
Figure 41: MEA Veterinary Anti-Infectives Market Attractiveness Analysis, 2017–2025, by Country
Figure 42: MEA Veterinary Anti-Infectives Market Attractiveness Analysis, 2017–2025, by Species Type
Figure 43: MEA Veterinary Anti-Infectives Market Attractiveness Analysis, 2017–2025, by Drug Class
Figure 44: MEA Veterinary Anti-Infectives Market Attractiveness Analysis, 2017–2025, by Mode of Administration
Figure 45: MEA Veterinary Anti-Infectives Market Attractiveness Analysis, 2017–2025, by Distribution Channel
Figure 46: Global Veterinary Anti-Infectives Market Share Analysis (%) By Region, 2017 & 2025
Figure 47: Global Veterinary Anti-Infectives Market Y-o-Y Growth (%) By Region, 2016–2025
Figure 48: Global Veterinary Anti-Infectives Market Absolute $ Opportunity (US$ Mn) By North America, 2017–2025
Figure 49: Global Veterinary Anti-Infectives Market Absolute $ Opportunity (US$ Mn) By Latin America, 2017–2025
Figure 50: Global Veterinary Anti-Infectives Market Absolute $ Opportunity (US$ Mn) By Europe, 2017–2025
Figure 51: Global Veterinary Anti-Infectives Market Absolute $ Opportunity (US$ Mn) By APAC, 2017–2025
Figure 52: Global Veterinary Anti-Infectives Market Absolute $ Opportunity (US$ Mn) By MEA, 2017–2025
Figure 53: Global Veterinary Anti-Infectives Market Attractiveness Analysis By Region, 2017–2025
Figure 54: Global Veterinary Anti-Infectives Market Share Analysis (%) By Species Type, 2017 & 2025
Figure 55: Global Veterinary Anti-Infectives Market Y-o-Y Growth (%) By Species Type, 2016–2025
Figure 56: Global Veterinary Anti-Infectives Market Absolute $ Opportunity (US$ Mn) By Livestock Animals, 2017–2025
Figure 57: Global Veterinary Anti-Infectives Market Absolute $ Opportunity (US$ Mn) By Companion Animals, 2017–2025
Figure 58: Global Veterinary Anti-Infectives Market Attractiveness Analysis By Species Type, 2017–2025
Figure 59: Global Veterinary Anti-Infectives Market Share Analysis (%) By Drug Class, 2017 & 2025
Figure 60: Global Veterinary Anti-Infectives Market Y-o-Y Growth (%) By Drug Class, 2016–2025
Figure 61: Global Veterinary Anti-Infectives Market Absolute $ Opportunity (US$ Mn) By Antimicrobial Agents, 2017–2025
Figure 62: Global Veterinary Anti-Infectives Market Absolute $ Opportunity (US$ Mn) By Antiviral Agents, 2017–2025
Figure 63: Global Veterinary Anti-Infectives Market Absolute $ Opportunity (US$ Mn) By Antifungal Agents, 2017–2025
Figure 64: Global Veterinary Anti-Infectives Market Absolute $ Opportunity (US$ Mn) By Antiparasitic Agents, 2017–2025
Figure 65: Global Veterinary Anti-Infectives Market Absolute $ Opportunity (US$ Mn) By Others, 2017–2025
Figure 66: Global Veterinary Anti-Infectives Market Attractiveness Analysis By Drug Class, 2017–2025
Figure 67: Global Veterinary Anti-Infectives Market Share Analysis (%) By Mode of Administration, 2017 & 2025
Figure 68: Global Veterinary Anti-Infectives Market Y-o-Y Growth (%) By Mode of Administration, 2016–2025
Figure 69: Global Veterinary Anti-Infectives Market Absolute $ Opportunity (US$ Mn) By Oral Route, 2017–2025
Figure 70: Global Veterinary Anti-Infectives Market Absolute $ Opportunity (US$ Mn) By Parenteral Route, 2017–2025
Figure 71: Global Veterinary Anti-Infectives Market Absolute $ Opportunity (US$ Mn) By Topical Route, 2017–2025
Figure 72: Global Veterinary Anti-Infectives Market Attractiveness Analysis By Mode of Administration, 2017–2025
Figure 73: Global Veterinary Anti-Infectives Market Share Analysis (%) By Distribution Channel, 2017 & 2025
Figure 74: Global Veterinary Anti-Infectives Market Y-o-Y Growth (%) By Distribution Channel, 2016–2025
Figure 75: Global Veterinary Anti-Infectives Market Absolute $ Opportunity (US$ Mn) By Veterinary Hospitals, 2017–2025
Figure 76: Global Veterinary Anti-Infectives Market Absolute $ Opportunity (US$ Mn) By Veterinary Clinics, 2017–2025
Figure 77: Global Veterinary Anti-Infectives Market Absolute $ Opportunity (US$ Mn) By Pharmacies, 2017–2025
Figure 78: Global Veterinary Anti-Infectives Market Absolute $ Opportunity (US$ Mn) By Others, 2017–2025
Figure 79: Global Veterinary Anti-Infectives Market Attractiveness Analysis By Distribution Channel, 2017–2025
Figure 80: Global Veterinary Anti-Infectives Market Value Analysis and Forecast, 2017–2025 (US$ Mn)
Figure 81: Global Veterinary Anti-Infectives Market Absolute $ Opportunity (US$ Mn), 2012-2016
Figure 82: Global Veterinary Anti-Infectives Market Absolute $ Opportunity (US$ Mn), 2016–2025